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Atrial fibrillation (AF) is a significant contributor to cardiovascular morbidity and mortality.
The currently available treatments are limited and AF continues to be a major clinical
challenge. Clinical studies have shown that AF is frequently associated with dysfunction
in the sino-atrial node (SAN). The association between AF and SAN dysfunction is
probably related to the communication between the SAN and the surrounding atrial
cells that form the SAN-atrial pacemaker complex and/or pathological processes that
affect both the SAN and atrial simultaneously. Recent evidence suggests that Ca2+
entry through TRPC3 (Transient Receptor Potential Canonical-3) channels may underlie
several pathophysiological conditions -including cardiac arrhythmias. However, it is still
not known if atrial and sinoatrial node cells are also involved. In this article we will first
briefly review TRPC3 and IP3R signaling that relate to store/receptor-operated Ca2+
entry (SOCE/ROCE) mechanisms and cardiac arrhythmias. We will then present some
of our recent research progress in this field. Our experiments results suggest that
pacing-induced AF in angiotensin II (Ang II) treated mice are significantly reduced in mice
lacking the TRPC3 gene (TRPC3−/− mice) compared to wild type controls. We also show
that pacemaker cells express TRPC3 and several other molecular components related
to SOCE/ROCE signaling, including STIM1 and IP3R. Activation of G-protein coupled
receptors (GPCRs) signaling that is able to modulate SOCE/ROCE and Ang II induced
Ca2+ homeostasis changes in sinoatrial complex being linked to TRPC3. The results
provide new evidence that TRPC3 may play a role in sinoatrial and atrial arrhythmias that
are caused by GPCRs activation.
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Introduction
The Role of Intracellular ca2+ in Sinoatrial Arrhythmias
In the normal heart, pacemaker cells in the sinoatrial node (SAN) generate spontaneous mem-
brane depolarizations that trigger action potentials, which then propagate through the conduction
system to initiate atrial and ventricular cell depolarization and contraction. In contrast to normal
pacemaker activity, abnormal arrhythmogenic electrical activity can arise in ectopic sites due to
impulse re-entry or abnormal spontaneous membrane depolarizations (Nattel, 2002).
SAN and the surrounding atria form the SAN-Atrial pacemaker complex, which can provide
substrates for re-entrant activity that can lead to AF (Sanders et al., 2004; Fedorov et al., 2010).
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Dysfunction of pacemaker ion channels, including altered HCN4
channels, are associated with familial tachycardia-bradycardia
syndrome and atrial fibrillation (Duhme et al., 2013). While it
is clear that cardiac arrhythmias, including SAN dysfunction
and atrial fibrillation (AF), are multifactorial there is increasing
experimental evidence for abnormal Ca2+ handling being a key
factor (Dobrev and Nattel, 2008; Yeh et al., 2008) and is the focus
of this paper.
The most prominent Ca2+-dependent ionic current during
pacemaker activity is the Na/Ca exchange (NCX) current which
not only contributes to pacemaker current(s) but may also pro-
duce arrhythmogenic electrical activity (Sipido et al., 2006) which
is related to abnormalities in Ca2+ handling leading to abnor-
mal NCX currents (Hove-Madsen et al., 2004; Vest et al., 2005).
Spontaneous Ca2+ release events or “leak” via the ryanodine
receptor (RyR), the major cardiac SR Ca2+ release channel, will
produce depolarizing NCX current and contribute spontaneous
membrane depolarization(s) to feed the genesis of AF (for review
see Greiser et al., 2011; Wakili et al., 2011). In addition, AF
has also been linked to Ca2+ release via a second class of SR
Ca2+ release channel, inositol 1,4,5-trisphosphate receptor fam-
ily (IP3Rs) (Woodcock et al., 2000; Mackenzie et al., 2002; Li
et al., 2005; Berridge, 2009). Activation of IP3Rs by IP3 is linked
to the activation of G-protein coupled receptors (GPCRs) and
the phospholipase C (PLC)-IP3 signaling pathway (see Figure 1).
Activation of GPCRs by agonists such as angiotensin II (Ang II)
or endothelin-1 (ET-1) can cause SAN dysfunction (Neef et al.,
2010) and AF (Woodcock et al., 2000; Mackenzie et al., 2002; Li
et al., 2005).
FIGURE 1 | Signaling pathways involved in the activation of TRPC3.
The G-protein coupled receptor (GPCRs) activates phospholiase C (PLC),
resulting in generation of IP3 and diacylglycerol (DAG). IP3 activates its
receptor that leads to Ca2+ release from SR/ER and the depletion of
SR/ER Ca2+ store. The Ca2+ content change in the store can be
sensed by STIM1, the ER Ca2+ sensor and cause store-operated Ca2+
entry (SOCE) through TRPC3 channels. An additional or alternate
possibility is that DAG can directly activate TRPC3, and produce
receptor-operated Ca2+ entry (ROCE). GPCRs, G-protein coupled
receptors; IP3R, inositol 1,4,5-trisphosphate receptors; PLC,
Phospholipase C; ROCE, Receptor–operated Ca2+ entry; SOCE,
store-operated Ca2+ entry; SR/ER, sarco- endo-plasmic reticulum;
STIM1, stromal interacting molecule 1; TRPC3,4,6 canonical transient
receptor potential channel types 3,4,6; NCX Na/Ca exchange.
Previously, we reported that in mouse SAN, there is a sub-
stantial sarcolemmal Ca2+ influx upon SRCa2+ store depletion, a
phenomenon known as “store-operated Ca2+ entry” (SOCE) (Ju
et al., 2007; Ju and Allen, 2007). We also showed that type II IP3R
are functionally expressed and aﬀect Ca2+ handling and pace-
maker activity in the mouse SAN and whose activation would
lead to store depletion (Ju et al., 2011, 2012). The linkage between
IP3R activation and SOCE has proven elusive, but a potential
candidate, was found in HEK 293 cells expressing the Transient
Receptor Potential Canonical-3 (TRPC3) channel (see below)
(Kiselyov et al., 1998).
TRPC3, SOCE/ROCE, and STIM1
Studies on the transient receptor potential (TRP) gene from
Drosophila showed that it encodes a PLC-activated Ca2+ per-
meable channel. Subsequently, seven homologs of TRP chan-
nels have been identified in mammals, termed TRPC1 to TRPC7
(Montell et al., 2002). TRPCs are thought to be strong candidates
for the elusive SOCE pathway (for review see Salido et al., 2009).
We have found that the SAN expresses all TRPC subtypes except
TRPC5 (Ju et al., 2007). Among them, TRPC3 was the only sub-
type located in the surface membrane of pacemaker cells, making
this isoform the strongest candidate for the SOCE channel in
SAN (Ju et al., 2007).
Ca2+ influx can also be triggered as a direct consequence of
PLC activation and production of diacylglycerol (DAG) that is
independent of SR Ca2+ store depletion and forms a “receptor-
operated Ca2+ entry” (ROCE) pathway (Mohl et al., 2011)
(Figure 1). ROCE pathways may be closely related to SOCE
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because PLC activation can be enhanced by IP3-induced store
depletion. TRPC channels are non-selective Ca2+-permeable
cation channels which are activated by diacylglycerol (DAG) lib-
erated from the plasma membrane, triggered by agonist binding
to G protein—coupled receptors, such as angiotensin II and
endothelin-1 receptors. Treatment with antisense RNA, to inhibit
translation of endogenous TRPC3 mRNA, reduces Ca2+ influx
activated either by receptor stimulation or passive store depletion
(Wu et al., 2004; Worley et al., 2007). Therefore, it is possible that
TRPC3 is involved in both SOCE and ROCE (see Figure 1) (for
review see Birnbaumer, 2009).
Another important breakthrough in SOCE/ROCE research
was the identification of a new component of SOCE called stro-
mal interacting molecule 1 (STIM1) (Roos et al., 2005). STIM1
functions as an ER/SR Ca2+ sensor, probably via a STIM1 Ca2+
binding EF hand inside the SR/ER lumen. The activation of
SOCE requires STIM1 migration in the SR/ER membrane where
it interacts with other molecular components of the SOCE sys-
tem (Lewis, 2007). In addition, conformation coupling between
IP3R and TRPC3 has been suggested as amechanism of activation
of TRPC3 (Kiselyov et al., 1998) and a region in the C terminus
of TRPC3 has been shown to interact with IP3 receptor as well
as calmodulin (Calmodulin/IP3 receptor-binding region (Zhang
et al., 2001).
TRPC3 in cardiac cells provides a Ca2+ entry pathway that
is connected to pathological signaling of the heart such as in
cardiac hypertrophy (Onohara et al., 2006; Eder and Molkentin,
2011). However, there is little functional data on the role of
TRPC3 in pacemaker and atrial cells to date. In the present study,
we present new data suggesting that pacemaker cells expresses
the molecular components of SOCE/ROCE pathways, including
TRPC3, STIM1, and IP3R2. We present preliminary experiments
using TRPC3−/− mice and the specific TRPC3 channel blocker
Pyr10 to show that TRPC3 appears to be able to contribute to
sinoatrial and atrial arrhythmias induced by activation of GPCR
Ca2+ signaling.
Material and Methods
Animals
Colonies of TRPC3−/− mice (Hartmann et al., 2008) and their
wild-type litter mates were gifts from Prof. Housley’s laboratory
at University of New South Wales. The mice were deeply anes-
thetised with intra peritoneal pentobarbitone (1ml/2 kg) before
any procedures were carried out. All procedures on mice were
performed according to the guidelines of the National Health
and Medical Research Council of Australia and approved by the
Institutional Ethics Committee.
Electrophysiological Studies in
Langendorff-Perfused Hearts
Hearts were cannulated and perfused with a modified Tyrode’s
solution containing (in mM/L) 130 NaCl, 1.8 CaCl2, 1.2 MgCl,
5.4 KCl, 1.2 NaH2PO4, 12 NaHCO3, 11 glucose, 10 HEPES, with
pH adjusted to 7.4 with NaOH. Perfusion was set at a con-
stant flow rate of 2–2.5ml/min and solutions were oxygenated
with 95% O2–5% CO2. Electrical activity was recorded with
two miniature monopolar ECG electrodes (Harvard Apparatus)
placed on the atria and ventricle (Zhang et al., 2011). To deter-
mine the electrical conduction velocity of SAN and surrounding
atrial tissue, custom-made electrode arrays were used to record
the electrical activity from the isolated Langendorﬀ-perfused
hearts as described previously (Davies et al., 2014). To assess
atrial arrhythmogenesis, Langendorﬀ-perfused hearts from WT
and KO mice were subjected to programmed electrical stimula-
tion with three diﬀerent pacing protocols as described elsewhere
(Head et al., 2005; Zhang et al., 2011). Atrial tachycardia (AT)
was defined as a sequence of three or more atrial depolarizations
at the rate of 10Hz or more than 10Hz. AF were characterized
by irregular fibrillating waveforms. Sinus bradycardia was defined
as a 30% reduction of baseline heart rate (HR) from the control
condition. An arrhythmia index was calculated by the number
of mice that have pacing induced arrhythmias events/the total
number of mice in each group.
The Preparation of Intact SAN and Single
Pacemaker Cells
Intact SANs were micro-dissected from right atria as described
previously (Ju et al., 2007). The central SAN was identified
from anatomical land marks, including the superior vena cava,
the crista terminalis, and the interatrial septum (Marionneau
et al., 2005). For physiological experiments, the intact SANs were
continuously superfused with Tyrode’s solution at 33◦C.
Measurement of Intracellular Ca2+, SOCE and
ROCE
The isolated SANs were loaded with membrane-permeant fluo-
rescent Ca2+ indicators, indo-1-AM or Fluo-4-AM (10µM/L),
using established methods (Ju and Allen, 1998; Ju et al., 2003). To
measure Ca2+ influx through SOCE in sinoatrial tissue, prepa-
rations were exposed to a nominally Ca2+ free solution with the
SR CaATPase pump inhibitor, cyclopiazonic acid (CPA, 10µM)
for 15min to deplete the SR Ca2+ store. SOCE then occurs upon
reintroduction of Ca2+ to the perfusate (Ju et al., 2007). ROCE
was determined by measuring the agonist-mediated increases in
[Ca2+]i (Ang II, 1µM/L and/or 1-oleoyl-2-acetyl-sn-glycerol -
OAG, 100µM/L) (Ikeda et al., 2013).
Immunohistochemistry
A rabbit polyclonal antibody was used to label type II IP3Rs
(1:200; Aﬃnity Bioreagents) and TRPC3 (1:100, Alomone Lab)
in single isolated pacemaker cells. A mouse antibody to STIM1
was also used (1:100, BD Biosciences). Anti-mouse or anti-rabbit
secondary antibodies (Alexa-488 anti-mouse and Alexa-594 anti-
rabbit (Molecular Probes) were used as secondary antibodies.
Prolong gold antifade reagent with DAPI (Molecular Probes) was
used as the mounting media and to provide nuclear staining.
Osmotic Mini-Pump Implantation
Alzet osmotic mini-pumps were implanted subcutaneously in
WT, or TRPC3−/− mice. Ang II was delivered at the rate of
2µg/g/day for 10–14 days.
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Statistics
Data are expressed as mean ± SEM, with the number of prepa-
rations as n. Statistical tests were either Student’s paired or
unpaired t-tests, and P < 0.05 was used as the limit of statistical
confidence.
Results
Evidence for TRPC3 Involvment in Atrial
Arrhythmias
Ang II signaling pathways lead to a hypertrophy which seems to
be related to TRPC3 expression (Onohara et al., 2006). To exam-
ine whether TRPC3 is involved in AF induced by Ang II, we
induced AF in mice by pacing Langendorﬀ-perfused hearts from
WT and TRPC3−/− KOmice which had been treated with Ang II
(See Methods) over of 10–14 days. Figure 2A shows the conduc-
tion of the AP across the SAN to the atria reconstructed from
the timing of the recorded electrical signals (panel below) using a
36mini electrode array placed on the right atrium. Atrial arrhyth-
mic events are illustrated in Figure 2B, and were induced by
using a pacing protocol that varied pacing voltage and frequency.
To investigate the possible role of TRPC3 in these arrhythmias,
we made ECG recordings from Langendorﬀ-perfused hearts
under control condition in WT and TRPC3−/− respectively, as
shown in the selected recordings illustrated in Figure 2C. Electri-
cal pacing induced AF, AT, and conduction block were recorded
and analyzed inWT and TRPC3−/−, respectively (exemplar data
shown in Figure 2D). We found that atrial arrhythmias induced
byAng II and pacing were significantly reduced in the TRPC3−/−
mice compared to the controls (P = 0.004, n = 11) (Figure 2E).
We previously reported that that pacemaker cells express
TRPC3 and it is preferentially localized to the surface mem-
brane (Ju et al., 2007). Therefore, the increased resistance to
arrhythmias in TRPC3−/− mice supports the idea of a possible
involvement of TRPC3 in arrhythmogenesis. As described above,
Ca2+ entry through TRPC3 channel activated via a SOCE/ROCE
signaling pathway and STIM1 could contribute arrhythmogenic
current. To investigate this possibility, we examined expres-
sion and molecular localisation of STIM1, and the possibility
of molecular interaction between TRPC3, STIM1, and IP3R2 in
isolated cardiac pacemaker cells.
Mouse Pacemaker Cells Express STIM1, a
Molecular Component of SOCE /ROCE
Previously, we demonstrated that mouse SAN tissue expressing
HCN4 mRNA also expressed TRPC3 (Ju et al., 2007). We also
found that pacemaker tissue express STIM1 mRNA and pro-
tein (Liu et al., 2015). In the present study we wanted to extend
these findings to the localisation of TRPC3 and STIM1 in sin-
gle isolated pacemaker cells. Figure 3 shows that isolated group
(Figure 3A) and single pacemaker cells (Figure 1B) were posi-
tively labeled with a HCN4 antibody (which is a common selec-
tive molecular marker for pacemaker cells). The cells isolated
from same SAN region were then double labeled with TRPC3
and STIM1 antibodies, and exemplar data is shown in Figure 3C.
TRPC3 (red) showed both a sarcomeric pattern as well as mem-
brane staining while STIM1 (green) displayed both cytosolic and
near membrane labeling. A previous study examined the interac-
tion of all mammalian TRPC channels with topically expressed
STIM1 and found that that the STIM1 ERM domain binds to
TRPC1, TRPC4, and TRPC5 but not TRPC3, TRPC6, and TRPC7
(Worley et al., 2007). However, knock down of STIM1 signifi-
cantly reduced the current carried by TRPC3 (Yuan et al., 2007).
The expression of both TRPC3 and STIM1 in cardiac pacemaker
cells suggested to us that TRPC3 could be involved in Ca2+ influx
through SOCE.
We have previously reported that pacemaker cells express
Type II IP3R (IP3R2) which can modulate pacemaker activ-
ity. To examine if IP3R and STIM1 form a signaling complex
in SAN we double labeled isolated pacemaker cells with anti-
IP3R2 and anti-STIM1 antibodies. Figure 3D shows that STIM1
labeling occurred both in cell periphery as well as inside the
cell. IR3R2 was similarly distributed and there was some co-
localization between these labels (yellow dots at the cell periph-
ery in merged image). To achieve higher resolution (∼100 nm),
a N-SIM/N-STORM super resolution microscope was used.
Figure 3E shows the higher resolution N-SIMmicroscope image,
which revealed tighter areas of co-localization between STIM1
and IP3R2. Given that the necessary molecular components of
SOCE/ROCE (including TRPC3, and STIM1) as well as IP3R are
present in pacemaker cells, we next examined if SOCE can be
modulated by IP3R activation.
Evidence for Interaction between IP3Rs and
SOCE in Mouse Pacemaker Tissue
To clarify if TRPC3 is involved in AF associated with GPCR
activation (Figure 2), we examined whether SOCE /ROCE could
be modified by GPCR activation. While we previously reported
that enhanced IP3R Ca2+ signaling modulated pacemaker firing
rate, it remains unknown whether IP3R agonists and antagonists
(which can modulate heart rate) also modulate SOCE activity in
SAN. Previous work on cardiac myocytes showed that overex-
pression of TRPC3 enhanced Ca2+ entry through SOCE while
knock down of TRPCs inhibited SOCE (Wu et al., 2010). We
therefore used the intact mouse SAN preparation loaded with
the ratiometric Ca2+ indicator indo-1 to study the interaction
between IP3Rs and SOCE.
After initial incubation of the SAN in Ca2+ free Tyrode’s with
the SR uptake blocked with CPA (10µmol/L), reintroduction of
Ca2+ (1.8mmol/L) caused a significant Ca2+ influx (i.e., SOCE)
as shown by an increase in Indo-1 ratio (Figure 4A). Importantly,
peak SOCE was increased by 63 ± 10% (n = 4, P < 0.05) in
the presence of ET-1, a representative trace of which is shown
in Figure 4A. Addition of the membrane permeant IP3 analog,
IP3-BM (10µmol/L) was also able to increase SOCE by 31 ±
10% (n = 3, data not shown). To test whether ET-1 or IP3-
BM acted by opening IP3R release channels and thereby causing
a greater store depletion (and hence SOCE), we examined the
eﬀect of enhancing store depletion by increasing both the CPA
concentration and the incubation time in Ca2+ free solution.
When the CPA concentration was increased from 10µmol/L to
20µmol/L and the incubation time in Ca2+ free buﬀer increased
from 15min to 30min ET-1 was no longer able to further increase
SOCE (Figure 4B). Similar results were found in three other
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FIGURE 2 | Atrial arrhythmias induced by Ang II and pacing.
Reconstructed excitation maps of data from multi-electrode array
recordings (images below) from a Langendorff-perfused isolated heart.
(A) sinus rhythm and (B) pacing induced atrial tachycardia. Note in
AT, the ectopic beat starts from a different site to sinus rhythms. (C)
Representative ECG recordings from isolated heart from WT and
TRPC3 −/− mice under control conditions. (D) Atrial tachycardia and
atrial fibrillation induced by burst pacing in WT mice and
atrial-ventricular conduction block recorded from a TRPC−/− mouse
heart respectively. (E) On average, the arrhythmia index was significant
reduced in TRPC3KO mice (n = 8) compared to WT mice (n = 11,
P = 0.004).
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FIGURE 3 | Isolated single SAN cells express TRPC3, STIM1, and
IP3R2. Confocal immunofluorenscence images of isolated single
pacemaker cells. Isolated group (A) and single (B) pacemaker cells
were positively stained with anti HCN4 (in green). (C) Anti-TRPC3 in
red, anti-STIM1 in green. (D) Anti-IP3R2 in red, anti-STIM1 in green. (E)
3D reconstruction image using N-SIM microscopy. Anti-IP3R2 in red,
anti-STIM1 in green. Areas of co-localisation appear yellow due to color
mixing.
SAN preparations. These results suggest that ET-1 exerts its
eﬀects on SOCE via activation of IP3Rs and caused Ca2+ release
and store depletion rather than by direct stimulation of SOC
channels.
Previous studies found that membrane permeant 2-APB has
a direct eﬀect on SOCE in some cell types, independent of its
action as an IP3R antagonist.(Bootman et al., 2002) We tested
this possibility by adding 40µmol/L 2-APB at the same time
that Ca2+ was reintroduced to the solution (Figure 4C). Ca2+
influx through SOCE was not inhibited by 2-APB under these
conditions, suggesting that 2-APB is not working as a direct
SOCE channel blockers such as gadolinium or SKF-96365 (Ju
et al., 2007). However, if 2-APB was added 15min before rein-
troduction of Ca2+, Ca2+ entry via SOCE was then significantly
inhibited (Figure 4D). On average, Ca2+ entry through the SOCE
channel with 2-APB decreased by 78 ± 8% (n = 4, P < 0.01).
Thus, 2-APB does not serve as a classic SOCE channel blocker
in pacemaker cells, but can inhibit SOCE by a slower mechanism
which may involve IP3R2 regulation as suggested previously (Ma
et al., 2000). Although the specificity of 2-APB is questionable, we
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FIGURE 4 | Modulation of store-operated Ca entry (SOCE) by ET-1
and 2-APB. SOCE was induced by using cyclopiazonic acid (CPA) and
low external Ca2+. The addition timing of extracellular Ca2+ change is
indicated in the top panels. (A) The effect of ET-1 on SOCE induced by
10µM CPA with 15min incubation in Ca2+ free Tyrode’s solution. (B)
The effect of ET-1 on SOCE induced by 20µM CPA with 30min
incubation in Ca2+ free Tyrode’s solution. (C) The effect of 40µM
2-APB on SOCE. 2-APB was added in the same time of reintroduction
of extracellular Ca2+ after perfusion of Ca2+ free Tyrode’s Solution
containing 10µM CPA. (D) The effect of 40µM 2-APB on SOCE.
2-APB was added into the Ca2+ free Tyrode’s solution with 10µM CPA
during the 15min incubation period. The gray traces represent controls;
the black traces represent the treatments with ET-1 (A,B) or 2-APB
(C,D), respectively.
found that the eﬀect of 2-APB was diminished in IP3R2 KO, also
supporting the involvement of IP3R2 in the slower onset eﬀects
of 2-APB on SOCE. These data are consistent with a previous
study that suggested 2-APB blocks activation of TRPC3 indirectly
via disruption of the coupling process between SOCE, TRPC and
IP3R (Ma et al., 2002).
Evidence TRPC3 is Involved in ROCE in
Intact Mouse Sinoatrial Node
TRPC3 has been implicated in not only SOCE but also ROCE
(see Introduction) (for review see Birnbaumer, 2009). To fur-
ther examine if Ca2+ influx through ROCE contributes to
Ang II-induced arrhythmias we measured action potentials and
Ca2+ influx in isolated SAN-atrial preparations treated with
Ang II (1µM) and/or OAG (100µM), the agonists known to
activate ROCE (Ikeda et al., 2013). Pyr3, a pyrazole deriva-
tive, has been suggested to be a blocker of TRPC3 (Kiyonaka
et al., 2009) but it inhibits Orai1 mediated SOCE with similar
potency (Salmon and Ahluwalia, 2010). Recently, a new selec-
tive blocker of TRPC3-ROCE blocker, Pyr10 has been developed
and it displayed substantial selectivity for TRPC3-ROCE medi-
ated responses over Orai1 mediated SOCE (Schleifer et al., 2012).
We therefore studied the eﬀect of Pyr10 on pacemaking and
intracellular Ca2+ after application of Ang II and/or the DAG
derivative, OAG.
Figure 5 shows action potentials recorded from an intact
sinoatrial node preparation using conventional intracellular
recording techniques. After application of 1µM Ang II for
30min, there was an increase in pacemaker firing rate associ-
ated with a depolarised membrane potential (Figure 5B). Appli-
cation of 2µM Pyr10 for 20min, slowed pacemaker firing rate
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FIGURE 5 | The effect of angiotension II (Ang II) and a selective TRPC3 channel blocker Pyr10 on pacemaker action potential after application of Ang
II. (A–D) Intracellular recordings from WT mice; (E–H) Intracellular recordings from TRPC3−/− mice with conditions as indicated in each panel.
with maximum diastolic potential returning to the control level
(Figure 5C). Application of 20µM Pyr10 further reduced fir-
ing rate within 7min (Figure 5D). These results suggest that the
membrane depolarization caused by Ang II could be reversed by
the TRPC3 channel blocker. The results also support the idea that
TRPC3 could be a channel that produces an inward current after
GPCR activation by Ang II (Onohara et al., 2006). Importantly,
and in contrast to WTmice, the pacemaker firing rate and action
potential depolarization were not aﬀected by Ang II and this
response not significantly altered by application of Pyr10 to SAN
from TRPC3 KO mice (Figures 5E–H). This is consistent with
pacing induced AF in mice treated with Ang II being reduced
in TRPC3−/− mice. (Figure 2) Therefore, these results strongly
suggest that Pyr10 not only specifically blocked TRPC3 channels
but that TRPC3 also contributes to pacemaker activity. To fur-
ther investigate if the changes in pacemaker activity were related
to Ca2+ entry through ROCE we examined intracellular Ca2+
changes caused by OAG and the eﬀect of Pyr10. Figure 6Aa
shows a representative intracellular Ca2+ signal recorded from
a WT intact sinoatrial preparation loaded with the Ca2+ indica-
tor indo-1. Both resting Ca2+ and Ca2+ transients were increased
after 20min application of 100µM OAG (Figure 6Ab). Resting
Ca2+ returned to the control level associated with a slowed fir-
ing rate after application of 2µM Pyr10 for 15min (Figure 6Ac).
Further slowing and irregular pacemaker activity was appar-
ent when the concentration of Pyr10 was increased to 20µM
for 15min as shown in Figure 6Ad. On average, resting Ca2+
increased by 20.2 ± 6.9% (P = 0.023, n = 5); the Ca2+ tran-
sient also increased by 26.1 ± 5.6% (p = 0.003, n = 5) and
was associated with a 13.9% increase in pacemaker firing rate
(p = 0.005, n = 5,) in response to OAG treatment. There no
significant changes by OAG in TRPC3 KO groups (n = 4) as
shown in Figure 6B. The results further confirmed that TRPC3
was involved in OAG produced Ca2+ entry through ROCE upon
GPCR activation. 2µM Pyr10 significantly reduced the resting
Ca2+ elevation produced by OAG treatment in WT but not in
TRPC3 KOmice (Figure 6C). Unexpectedly, PyR10 produced no
significant changes in Ca2+ transient amplitude and firing rate in
both groups after exposure to OAG. The results indicated that
Ca2+ entry through ROCE appeared to mainly influence resting
Ca2+ in pacemaker cells and the lack of eﬀect of PYR10 after
OAG stimulation on the Ca2+ transient and pacemaker firing
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rate may reflect additional eﬀect(s) of PyR10 beyond TRPC3. In
support of the latter idea, 20µM Pyr10 reduced the amplitude
of the Ca2+ transient in TRPC3 KO mice without significantly
changing pacemaker firing rate or resting Ca2+ level (data not
show).
Discussion
TRPC3 and Sino-Atrial Arrhythmias
In this study, we found that pacing-induced atrial fibrillation
in angiotensin II treated mice was significantly reduced in mice
lacking the TRPC3 gene (TRPC3−/− mice). This suggests that
TRPC3 channels may be involved in Ang II induced changes in
the electrical properties of sinoatrial tissue. Recent evidence has
implicated Ca2+ entry through TRPC3 as a pro-arrhythmic path-
way (Harada et al., 2012). TRPC3 is known to be up-regulated in
AF patients and experimental goat and canine AF models and
also mediates a non-selective cation current in atrial fibroblasts
(Harada et al., 2012). TRPC3 has also been implicated in dys-
function of SAN (Yanni et al., 2011) and atrioventricular conduc-
tion block (Sabourin et al., 2012). Collectively, all of these studies
point to a functional role for TRPC3 activation in cardiac tissue
and linkage to arrhythmogenesis.
Some ryrazole derivatives have recently been suggested to be
relatively selective blockers for TRPC channels (Schleifer et al.,
2012). In WT mice, we showed that Pyr10, blocked the mem-
brane depolarization of SAN cause by Ang II and attenuated the
increase in pacemaker firing rate induced by Ang II (Figure 5).
A higher concentration of Pyr10 (20µM) induced slower and
irregular pacemaker activity without changing the upstroke of
the action potential (Figure 5D). The latter result suggests that
Pyr10 did not block L-type Ca channels which provide the main
cation current for the upstroke of pacemaker action potentials.
(Irisawa et al., 1993) This eﬀect of Pyr10 was similar to our pre-
vious observation using a diﬀerent SOCE inhibitor (SKF-96365)
(Ju et al., 2007). In contrast, Pyr10 did not cause any significant
changes in slowing pacemaker action potentials recorded from
sinoatrial tissue fromTRPC3−/−mice (Figure 5H). These results
suggest that Pyr10 is mainly active on a SAN diastolic membrane
current, and is in accord with the idea that TRPC3 activation
can provide a non-selective cation current in pacemaker cells
(Eder and Molkentin, 2011). Intracellular Ca2+ measurements
also showed that GPCR activation by Ang II or the DAG analog,
OAG, caused an increase in both resting Ca2+ and Ca2+ tran-
sients that were associated with increased pacemaker firing rate in
WTmice (Figure 6). The increased resting Ca2+ seemed directly
related to ROCE as resting Ca2+ was significantly reduced in the
presence of ROCE blocker, Pyr10 (Figure 6C). In contrast, such
changes were absent in the TRPC3 −/− group. These results pro-
vide further evidence that TRPC3 is involved in regulation of
intracellular Ca2+ and ROCE mechanisms in SAN (Figure 6).
Interaction between IP3R and SOCE in Cardiac
Pacemaker Tissue
It has become generally accepted that Ca2+ release from the SR
contributes to pacemaker activity through its influence on NCX
currents (Ju and Allen, 2001; Vinogradova et al., 2005; Maltsev
and Lakatta, 2008). Alterations in Ca2+ metabolism and conse-
quent changes in Ca2+ dependent currents (such as NCX) have
also been implicated in failure of pacemaker function and cardiac
arrhythmias (Du and Nathan, 2007; Maltsev and Lakatta, 2007).
We previously reported that IP3Rs are expressed in murine
SAN and that the predominant isoform is the Type II IP3R
(IP3R2) (Ju et al., 2011). Importantly, the modulation of pace-
maker firing and intracellular Ca2+ by IP3R-agonists and antag-
onists was abolished in IP3R2 KO mice, demonstrating a clear
functional, modulatory, role for IP3R2 in SAN. The present study
also supports the idea that Ca2+ release via IP3Rs can modu-
late heart rate, depending on the activation of G-protein coupled
receptors and the phospholipase C-IP3 signaling pathway.
In non-excitable cells and smoothmuscle, it has also been sug-
gested that SOCE are coupled to IP3Rs (Putney, 1986). Since the
discovery of TRPC channels and their candidacy for the SOCE,
interactions between IP3Rs and members of the TRPC family
have been reported (Vazquez et al., 2004). For example, it has
been shown that IP3R2 interacts with TRPC3 forming a protein
complex that possibly underlies the enhanced SOCE activity seen
in gravid uterine endothelium (Giﬀord et al., 2006). In the present
study, we show that Ca2+ influx through SOCE in the SAN can
be modulated by IP3 agonists(ET-1, IP3-BM) and IP3R2 antag-
onists (2-APB) through mainly their eﬀect on increasing Ca2+
release and hence reducing store content (see Figure 4). Since
some IP3Rs appear to be localized near the surface membrane,
where TRPC3 is also located (Ju et al., 2007, 2011), it is possible
that Ca2+ release via IP3Rs could interact with these ion channels
in the surface membrane (and/or aﬀect their traﬃcking). IP3R
expression has been shown to increase in heart failure (Marks,
2000) and in atrial fibrillation (Yamada et al., 2002), which raises
the possibility that this IP3-TRPC signaling system may become
more important in pathological conditions (Worley et al., 2007;
Ju et al., 2012).
SOCE over ROCE in Cardiac Tissue
As described above, SOCE and ROCE may be linked
phenomena but the extent to which these mechanisms
cross-communicate/activate is unclear -especially after GPCR
activation of PLC which triggers formation of IP3 and DAG (Liao
et al., 2009). While it has been established that TRPC3 is involved
in ROCE (Hofmann et al., 1999), it remains uncertain whether
TRPC3 can also contribute to SOCE (for review see Cahalan,
2009) (Zagranichnaya et al., 2005; Dehaven et al., 2009).
We showed that TRPC3 expressing pacemaker cells also
express the ER-Ca2+ sensor protein, STIM1. The latter may pro-
vide the missing molecular signaling link between Ca2+ release
via IP3Rs, store depletion and the activation of SOCE(Lewis,
2007; Yuan et al., 2007). However, it remains unclear whether
STIM1 directly regulates the TRPC channels related to SOCE
(Worley et al., 2007; Yuan et al., 2007; Dehaven et al., 2009).
In addition to TRPCs, Orai1 is a protein that may produce a
specific SOCE pathway and appears as a Ca2+ release activated
Ca2+ current (Icrac). While we found that Orai1 is expressed
in mouse pacemaker cells (not shown), TRPC3 was more dom-
inant at both mRNA and protein levels (Ju et al., 2007). It has
been suggested that TRPC3 and Orai1 may form a complex that
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FIGURE 6 | The effect of Pyr10 on intracellular Ca2+ after
application of 1-oleoy1-2-acyl-sn-glycerol (OAG) 100µM. The
intact SANs were loaded with Ca2+ indicator indo-1. (A,B) show
intracellular Ca2+ recordings from a WT mouse. (B,C) The statistics
pool data shows percentage changes in resting Ca2+, Ca2+ transient
and firing rate in WT and TRPC3 KO mice respectively. (B) OAG
treatment against control. (C) 2µM Pyr10 treatment against OAG
treatment. *P < 0.05.
mediates both SOCE and ROCE and the conversion from ROCE
to SOCE may be mediated through STIM1 binding (Liao et al.,
2008).
The Limitation of Current Study
The current study does not rule out the possibility that Pyr10 has
eﬀects on currents other than TRPC3, such as If . In addition, it
would be desirable to examine if other molecular components,
such as NCX, SERCA, etc. that regulate intracellular Ca2+ are
changed in TRPC3−/− mice. Despite these limitations, we shown
that Ca2+ entry through both SOCE and ROCE occurs in murine
SAN and appears to be regulated by the GPCRs in a GPCR≫
PLC≫ IP3R/DAG≫ Ca2+ signal transduction cascade. We sug-
gest that TRPC3 channels might provide a potential target for
future treatment of SAN dysfunction and AF as it links both
receptor activation and intracellular Ca2+ signaling.
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